← FDA Drug Approvals (Drugs@FDA)

CEFTAZIDIME

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACS DOBFAR · Approved 1985-11-20

Drug application

FDA Application #

ANDA062640

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEFTAZIDIME

Generic name

CEFTAZIDIME

Active ingredients

CEFTAZIDIME

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ACS DOBFAR

Manufacturer

Sagent Pharmaceuticals

First approval

1985-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown